RESEARCH - Increased risk of esophageal cancer with oral bisphosphonates

[Guest guest]

Osteoporosis Drugs May Be Linked to Cancer Risk

Study Shows Some Increased Risk of Esophageal Cancer From Oral Bisphosphonates

By Salynn Boyles

WebMD Health News

Reviewed by J. , MD

Sept. 2, 2010 -- The long-term use of oral bisphosphonate osteoporosis

drugs such as Actonel, Boniva, and Fosamax may be associated with a

doubling in esophageal cancer risk, but the risk to individual users

remains small, researchers say.

Compared to people who had never taken the medications, long-term

users of the bone-building drugs known as oral bisphosphonates had

nearly double the risk for the rare but deadly cancer in a newly

published study.

***************************************

Read the entire article here:

http://www.webmd.com/osteoporosis/news/20100902/osteoporosis-drugs-may-be-linked\

-to-cancer-risk

Not an MD